Objective:To compare the clinical effects of mortice and tenon joint and end-to-end bone contact of zygomatic arch in reduction malarplasty, and to explore the clinical application value of mortice and tenon joint.Methods:The clinical data of patients who underwent reduction malarplasty in Sichuan Friendship Hospital and West China Hospital of Stomatology, Sichuan University from January 2013 to June 2020 were analyzed retrospectively. All patients were treated with classical or modified L-shaped zygomatic arch osteotomy. According to the bone connection mode of the zygomatic arch, the patients were divided into Group Ⅰ and Group Ⅱ. The patients in Group Ⅰ were treated with mortice and tenon joint (from June 2017 to June 2020), and the ones in Group Ⅱ were treated with end-to-end contact (from January 2013 to May 2017). The movement between zygomatic body and zygomatic arch were measured 6-24 months after surgeries. The postoperative satisfaction rate was investigated, and the incidence of complications within 2 years after operation was recorded. The data were statistically analyzed by SPSS 20.0 software. The measurement data were expressed by Mean±SD, and the counting data were expressed by cases (%). T-test was used to compare the age difference, zygomatic body and zygomatic arch movement distance between the two groups. Chi-square test was used to compare the sex composition ratio, postoperative satisfaction rate (sum of very satisfied and satisfied cases/sum of cases in respective group) and incidence of complications between the two groups. P<0.05 was considered statistically significant. Results:A total of 380 patients presenting with zygomatic protrusion were included in this retrospective study. One hundred and ninety patients were included in Group Ⅰ[22 men and 168 women; aged(26.8 ±8.6) years)] and 190 patients in Group Ⅱ [16 men and 174 women; aged (25.2 ±8.8) years)]. There was no significant difference in sex constituent ratio and age between the two groups ( P>0.05). After the operation, the width of the face was narrowed, and the contour of the face was significantly improved. The medial movement distance of zygomatic body in Group Ⅰ and Group Ⅱ was (2.65±0.76) mm versus (2.51±0.78) mm, and the movement distance of zygomatic arch in Group Ⅰ and Group Ⅱ was (4.58 ±0.44) mm versus (2.60±0.28) mm. There was no significant difference in movement distance of zygomatic body between Group Ⅰ and Group Ⅱ ( t=1.77, P=0.077), but there was significant difference in the zygomatic arch ( t=52.33, P<0.001). The satisfaction rate of patients in Group Ⅰ was 75.8% (144/190), which was higher than that in Group Ⅱ (55.3%, 105/190) ( χ2=17.72, P<0.001). There was no significant difference in the incidence of postoperative infection, temporary paresthesia, and hematoma between the two groups ( P>0.05). The incidence of facial asymmetry, sagging cheek, bone suture and nonunion in Group Ⅱ was significantly higher than that in Group Ⅰ ( P<0.05). Conclusion:Compared with end-to-end bone contact in reduction malarplasty, the mortice and tenon joint of the zygomatic arch achieved better facial narrowing effect and long-term stability, higher patient satisfaction rate and less postoperative complications.

Objective:To compare the clinical effects of mortice and tenon joint and end-to-end bone contact of zygomatic arch in reduction malarplasty, and to explore the clinical application value of mortice and tenon joint.Methods:The clinical data of patients who underwent reduction malarplasty in Sichuan Friendship Hospital and West China Hospital of Stomatology, Sichuan University from January 2013 to June 2020 were analyzed retrospectively. All patients were treated with classical or modified L-shaped zygomatic arch osteotomy. According to the bone connection mode of the zygomatic arch, the patients were divided into Group Ⅰ and Group Ⅱ. The patients in Group Ⅰ were treated with mortice and tenon joint (from June 2017 to June 2020), and the ones in Group Ⅱ were treated with end-to-end contact (from January 2013 to May 2017). The movement between zygomatic body and zygomatic arch were measured 6-24 months after surgeries. The postoperative satisfaction rate was investigated, and the incidence of complications within 2 years after operation was recorded. The data were statistically analyzed by SPSS 20.0 software. The measurement data were expressed by Mean±SD, and the counting data were expressed by cases (%). T-test was used to compare the age difference, zygomatic body and zygomatic arch movement distance between the two groups. Chi-square test was used to compare the sex composition ratio, postoperative satisfaction rate (sum of very satisfied and satisfied cases/sum of cases in respective group) and incidence of complications between the two groups. P<0.05 was considered statistically significant. Results:A total of 380 patients presenting with zygomatic protrusion were included in this retrospective study. One hundred and ninety patients were included in Group Ⅰ[22 men and 168 women; aged(26.8 ±8.6) years)] and 190 patients in Group Ⅱ [16 men and 174 women; aged (25.2 ±8.8) years)]. There was no significant difference in sex constituent ratio and age between the two groups ( P>0.05). After the operation, the width of the face was narrowed, and the contour of the face was significantly improved. The medial movement distance of zygomatic body in Group Ⅰ and Group Ⅱ was (2.65±0.76) mm versus (2.51±0.78) mm, and the movement distance of zygomatic arch in Group Ⅰ and Group Ⅱ was (4.58 ±0.44) mm versus (2.60±0.28) mm. There was no significant difference in movement distance of zygomatic body between Group Ⅰ and Group Ⅱ ( t=1.77, P=0.077), but there was significant difference in the zygomatic arch ( t=52.33, P<0.001). The satisfaction rate of patients in Group Ⅰ was 75.8% (144/190), which was higher than that in Group Ⅱ (55.3%, 105/190) ( χ2=17.72, P<0.001). There was no significant difference in the incidence of postoperative infection, temporary paresthesia, and hematoma between the two groups ( P>0.05). The incidence of facial asymmetry, sagging cheek, bone suture and nonunion in Group Ⅱ was significantly higher than that in Group Ⅰ ( P<0.05). Conclusion:Compared with end-to-end bone contact in reduction malarplasty, the mortice and tenon joint of the zygomatic arch achieved better facial narrowing effect and long-term stability, higher patient satisfaction rate and less postoperative complications.

OBJECTIVETo investigate the effects of Xinfeng Capsule (XFC) on pulmonary function and related mechanism in adjuvant-induced arthritis (AA) rats.

METHODSThe rats were randomly divided into five groups: normal control (NC), model control (MC) groups, methotrexate (MTX), tripterygium glycosides tablet (TPT) and Xinfeng capsule (XFC) treatment groups. The adjuvant-induced arthritis model was established by intracutaneous injection of 0.1 mL Freund ' s complete adjuvant in the right paw of rats; the drugs were given 19 d after model establishment. The toe swelling degree (E), arthritis index (AI), pulmonary function, peripheral blood Treg levels, pathological changes of lung tissue and expression of Foxp3, TGF-β1, Smad3, Smad7 proteins in lung tissue were measured 30 d after drug administration.

RESULTSCompared to NC group, the levels of E, AI, alveolitis score, TGF-β1 and Smad3 were significantly increased (P <0.05 or P <0.01); maximum expiratory flow 25% of vital capacity (FEF25),50% maximal expiratory vital capacity flow (FEF50), maximum expiratory flow at 75% of vital capacity (FEF75), maximum mid-expiratory flow (MMF), force peak expiratory flow (PEF), CD4+ CD25+ Treg, Foxp3 and Smad7 were significantly decreased in MC group (P <0.05 or P < 0.01). Compared to MC group,the expression of E, AI, TGF-β1 and Smad3 were reduced, while FEF50, FEF75, MMF, PEF, Treg, Foxp3 and Smad7 were elevated in XFC group (P <0.05 or P <0.01). Compared to XFC group, the level of body mass,FEF25,FEF50, FEF75, MMF and Treg were lower in MTX and TPT groups (P <0.05 or P <0.01).

CONCLUSIONThere are inflamed joints and reduced pulmonary function in rats of adjuvant-induced arthritis. XFC can inhibit paw edema degrees, reduce arthritis response, and improve pulmonary function, which is associated with up-regulating expression of Treg and Foxp3, down-regulating the expression of TGF-β1 and adjusting TGF-β1/Smads signal pathway.

Animals ; Arthritis, Experimental ; drug therapy ; metabolism ; physiopathology ; Capsules ; Drugs, Chinese Herbal ; therapeutic use ; Forkhead Transcription Factors ; metabolism ; Lung ; drug effects ; pathology ; physiopathology ; Male ; Rats ; Rats, Wistar ; Smad3 Protein ; metabolism ; Smad7 Protein ; metabolism ; T-Lymphocytes, Regulatory ; metabolism ; Transforming Growth Factor beta1 ; metabolism

Reduction malarplasty is one of the most common facial profile plastic surgery techniques, which always operates accompanying with mandibular angloplasty and genioplasty to demonstrate gentle facial contour curve and aesthetic appearance. There are various kinds of surgical method of reduction malarplasty, such as I-shaped osteotomy, L-shaped osteotomy, zygomatic arch osteotomy and other modifications. These modified procedures are developed to reduce the zygomatic complex and make the facial contour harmonious and beautiful simultaneously, and each of these has its own advantages and indications. The purpose of this review is to introduce the protrusion types of zygomatic arch complex, surgical approaches, surgical method classifications, and clinical applications of reduction malarplasty.

Mandibular angle plasty aims to improve the lower facial contour through procedures such as masseter muscle resection, ostectomy in the mandibular angle area, and external cortex bone grinding. This surgery primarily addresses hypertrophic masseter muscle correction and hypertrophic mandibular angle bone correction. The procedure has evolved from modifications of mandibular angle osteotomy to advancements in digital surgical design, gradually integrating with zygomatic arch plasty and genioplasty to achieve more harmonious facial proportions. This paper systematically elaborated on the surgical design and clinical application of mandibular angle plasty, discussed its indications, summarized developmental trends, and proposed prospects for future advancements.

Mandibular angle plasty aims to improve the lower facial contour through procedures such as masseter muscle resection, ostectomy in the mandibular angle area, and external cortex bone grinding. This surgery primarily addresses hypertrophic masseter muscle correction and hypertrophic mandibular angle bone correction. The procedure has evolved from modifications of mandibular angle osteotomy to advancements in digital surgical design, gradually integrating with zygomatic arch plasty and genioplasty to achieve more harmonious facial proportions. This paper systematically elaborated on the surgical design and clinical application of mandibular angle plasty, discussed its indications, summarized developmental trends, and proposed prospects for future advancements.

Reduction malarplasty is one of the most common facial profile plastic surgery techniques, which always operates accompanying with mandibular angloplasty and genioplasty to demonstrate gentle facial contour curve and aesthetic appearance. There are various kinds of surgical method of reduction malarplasty, such as I-shaped osteotomy, L-shaped osteotomy, zygomatic arch osteotomy and other modifications. These modified procedures are developed to reduce the zygomatic complex and make the facial contour harmonious and beautiful simultaneously, and each of these has its own advantages and indications. The purpose of this review is to introduce the protrusion types of zygomatic arch complex, surgical approaches, surgical method classifications, and clinical applications of reduction malarplasty.